Metastatic prostate cancer
Showing 1 - 25 of >10,000
Metastatic Prostate Cancer Trial in Nanjing (177Lu-PSMA-0057)
Recruiting
- Metastatic Prostate Cancer
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Sep 17, 2023
A Journey Into Participation Patterns Among Metastatic Prostate
Not yet recruiting
- Metastatic Prostate Cancer
-
San Francisco, CaliforniaPower Life Sciences
Aug 18, 2023
PROSTATE CANCER, Metastatic Prostate Cancer, Metastatic Prostate Carcinoma Trial in Boston (Supervised Circuit Training)
Not yet recruiting
- PROSTATE CANCER
- +2 more
- Supervised Circuit Training
-
Boston, Massachusetts
- +2 more
Sep 13, 2023
Optimizing Announcement of Advanced or Metastatic Prostate
Not yet recruiting
- Prostate Cancer
- Animated video
-
Neuilly-sur-Seine, France
- +2 more
Oct 31, 2023
Advanced Prostate Cancer, Metastatic Prostate Cancer Trial (RO7656594)
Not yet recruiting
- Advanced Prostate Cancer
- Metastatic Prostate Cancer
- (no location specified)
Mar 24, 2023
Metastatic Prostate Cancer in Pirkanmaa Hospital District in
Not yet recruiting
- Metastatic Castration Sensitive Prostate Cancer (mCSPC)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- abiraterone
- +10 more
- (no location specified)
Jan 17, 2023
Liquid Biopsy Genomic Profiling on Treatment Metastatic Prostate
Recruiting
- Metastatic Prostate Cancer
- Liquid Biopsy
- Archival Tumor DNA sequencing
-
Barcelona, SpainSOLTI Cancer Research Group
May 22, 2023
Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)
Recruiting
- Prostate Cancer
- Metastatic Prostate Cancer
- Abiraterone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Feb 21, 2023
Prostate Cancer Trial in Bellinzona (Lifestyle intervention)
Not yet recruiting
- Prostate Cancer
- Lifestyle intervention
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland (IOSI)
May 5, 2023
Prostate Metastases Trial in Toronto (Radiotherapy)
Not yet recruiting
- Prostate Metastases
- Radiotherapy
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Dec 9, 2022
Prostate Cancer Trial in Beijing, Shanghai (Phase I:[177Lu]Lu-XT033 Injection, Phase II:[177Lu]Lu-XT033 Injection)
Not yet recruiting
- Prostate Cancer
- Phase I:[177Lu]Lu-XT033 Injection
- Phase II:[177Lu]Lu-XT033 Injection
-
Beijing, Beijing, China
- +1 more
Oct 7, 2023
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))
Active, not recruiting
- Prostate Cancer
- +5 more
- 131I-PSMA-1095 Radioligand Therapy (RLT)
-
Montreal, Quebec, CanadaStephan Probst
Oct 24, 2022
Novel Therapy Target in Metastatic Prostate Cancer
Not yet recruiting
- Prostate Neoplasms
- Tissue
- (no location specified)
Oct 10, 2022
Prostate Cancer Metastatic Trial in Ghent (radical prostatectomy, Whole pelvis radiotherapy)
Recruiting
- Prostate Cancer Metastatic
- radical prostatectomy
- Whole pelvis radiotherapy
-
Ghent, BelgiumUniversity Hospital Ghent
Dec 16, 2022
Metastatic Prostate Cancer, Neuroendocrine Prostate Cancer Trial in Detroit, New York, Lancaster (ORIC-944)
Recruiting
- Metastatic Prostate Cancer
- Neuroendocrine Prostate Cancer
-
Detroit, Michigan
- +2 more
Sep 19, 2022
Testing Circulating Tumour DNA for Homologous Recombination Gene
Recruiting
- Circulating Tumor DNA
- Metastatic Prostate Cancer
- Blood sample
- Urine sample
-
Tours, FranceUniversity hospital
Sep 6, 2022
Prostate Cancer Metastatic Trial (SABR, no RT)
Not yet recruiting
- Prostate Cancer Metastatic
- SABR
- no RT
- (no location specified)
Jul 11, 2022
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial
Active, not recruiting
- Hormone-Resistant Prostate Cancer
- +6 more
- Pembrolizumab
- pTVG-HP Plasmid DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 8, 2022
Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic
Not yet recruiting
- Metastatic Malignant Neoplasm in the Viscera
- +4 more
- Lutetium Lu 177 Dotatate
- (no location specified)
Jan 25, 2023
Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A
Not yet recruiting
- Metastatic Prostate Cancer
- +2 more
- Darolutamide
- +4 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 14, 2022
Patients With Metastatic Castration-resistant Prostate Cancer Trial (177Lu-PSMA-617 PET scan)
Not yet recruiting
- Patients With Metastatic Castration-resistant Prostate Cancer
- 177Lu-PSMA-617 PET scan
- (no location specified)
Nov 13, 2023
Metastatic Prostate Cancer Trial in Cleveland (Exercise therapy)
Not yet recruiting
- Metastatic Prostate Cancer
- Exercise therapy
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 2, 2022
Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer, Chemo Effect Trial in Nanjing (Docetaxel, Rezvilutamide)
Recruiting
- Metastatic Prostate Cancer
- +2 more
-
Nanjing, Jiangsu, ChinaUrology dpt, First Affiliated Hospital of Nanjing Medical Univer
Aug 2, 2023
Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)
Active, not recruiting
- Prostate Cancer
- engineered autologous T cells
- cyclophosphamide
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 28, 2022
Prostate Cancer, Recurrent Prostate Cancer Trial in Tampa (F-DCFPyL Injection, PSMA PET)
Recruiting
- Prostate Cancer
- Recurrent Prostate Cancer
- F-DCFPyL Injection
- PSMA PET
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023